Medicare Enrolled
Dr. Massarat Bala, M.D.
Internal Medicine · Schaumburg, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bala from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bala?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bala
Dr. Massarat Bala is an internal medicine specialist in Schaumburg, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bala performed 2,150 Medicare services across 1,133 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bala received a total of $18,522 from 57 pharmaceutical and/or device companies across 849 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bala is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 14% volume in IL
$18,522 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,150
Medicare services
Top 14% in IL for internal medicine
1,133
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~113 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
434 | $52 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
317 | $106 | $417 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
183 | $70 | $294 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
165 | $40 | $75 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
154 | $33 | $131 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
123 | $137 | $450 |
| Annual alcohol misuse screening, 5 to 15 minutes | 120 | $19 | $60 |
| Annual intensive behavioral therapy for cardiovascular disease, 15 minutes A yearly, in-person session focused on intensive behavioral therapy to help manage cardiovascular disease. The session lasts for 15 minutes and is conducted with the patient individually. |
117 | $28 | $87 |
| Annual depression screening | 115 | $19 | $60 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
113 | $86 | $273 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
99 | $41 | $161 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
97 | $41 | $199 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
51 | $12 | $49 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
21 | $5 | $16 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
21 | $44 | $170 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
20 | $12 | $46 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$18,522
Total received (2018-2024)
Avg $2,646/year across 7 years
Top 4% in IL for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
849
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,080 (97.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$442 (2.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,158
2023
$1,983
2022
$2,983
2021
$3,559
2020
$2,741
2019
$3,013
2018
$2,084
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$550
Boehringer Ingelheim Pharmaceuticals, Inc.
$312
AstraZeneca Pharmaceuticals LP
$245
PFIZER INC.
$206
Lilly USA, LLC
$199
Novo Nordisk Inc
$126
Otsuka America Pharmaceutical, Inc.
$80
Dexcom, Inc.
$74
Corcept Therapeutics
$72
Amgen Inc.
$59
Exact Sciences Corporation
$59
Xeris Pharmaceuticals, Inc.
$45
GlaxoSmithKline, LLC.
$34
SANOFI-AVENTIS U.S. LLC
$29
Seqirus USA Inc
$26
E.R. Squibb & Sons, L.L.C.
$25
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$16
Top 3 companies account for 51.3% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,035
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,688
Novo Nordisk Inc
$1,441
Lilly USA, LLC
$1,408
Janssen Pharmaceuticals, Inc
$1,292
PFIZER INC.
$1,179
ABBVIE INC.
$899
Dexcom, Inc.
$892
Amarin Pharma Inc.
$821
AbbVie Inc.
$729
GlaxoSmithKline, LLC.
$716
E.R. Squibb & Sons, L.L.C.
$602
Novartis Pharmaceuticals Corporation
$600
Astellas Pharma US Inc
$566
Merck Sharp & Dohme Corporation
$385
SANOFI-AVENTIS U.S. LLC
$360
Bayer HealthCare Pharmaceuticals Inc.
$279
Amgen Inc.
$265
Allergan, Inc.
$223
Biohaven Pharmaceuticals, Inc.
$188
Otsuka America Pharmaceutical, Inc.
$155
PREVENTRIC DIAGNOSTICS, INC.
$143
Mallinckrodt Hospital Products Inc.
$125
Xeris Pharmaceuticals, Inc.
$111
DEXCOM, INC.
$107
Ultragenyx Pharmaceutical Inc.
$98
Corcept Therapeutics
$93
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$90
Abbott Laboratories
$89
Nestle HealthCare Nutrition Inc.
$81
Mannkind Corporation
$71
Horizon Therapeutics plc
$70
Bayer Healthcare Pharmaceuticals Inc.
$66
MannKind Corporation
$66
Exact Sciences Corporation
$59
Biohaven Pharmaceutical Holding Company Ltd.
$59
Allergan Inc.
$41
Bardy Diagnostics, Inc.
$39
DERMIRA, INC.
$37
Boston Scientific Corporation
$32
Hologic, LLC
$29
Kowa Pharmaceuticals America, Inc.
$27
Seqirus USA Inc
$26
Sunovion Pharmaceuticals Inc.
$26
Teva Pharmaceuticals USA, Inc.
$25
Shire North American Group Inc
$21
Edwards Lifesciences Corporation
$21
Esperion Therapeutics, Inc.
$20
Shield Therapeutics Inc
$18
LINUS HEALTH, INC.
$17
Philips Electronics North America Corporation
$16
Lucid Diagnostics Inc.
$16
Merck Sharp & Dohme LLC
$15
Genentech USA, Inc.
$13
Melinta Therapeutics, Inc.
$12
LifeScan, Inc.
$11
ARBOR PHARMACEUTICALS, INC.
$11
Top 3 companies account for 27.9% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ACTHAR · ADVAIR · AFREZZA · AIMOVIG · AIRSUPRA · Aimovig · Aptima Combo 2 · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BPRO BT AMBULATORY BLOOD PRESSURE MONITORING SYSTEM · BREZTRI · BREZTRI AEROSPHERE · BYSTOLIC · CAMZYOS · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CORE COGNITIVE EVALUATION · CREON · Carnation Ambulatory Monitor · Cologuard Collection Kit · Cryvista · DEXCOM G6 TRANSMITTER · DUEXIS · Dexcom G6 Transmitter · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Edarbyclor · FARXIGA · FASENRA · FREESTYLE LIBRE 2 · Fluad · FreeStyle Libre · GVOKE HYPOPEN · INVOKANA · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · Korlym · LINZESS · LONHALA MAGNAIR · LYRICA · Livalo · MOUNJARO · MYRBETRIQ · Myrbetriq · NATPARA · NEXLETOL · NURTEC ODT · Neuromodulation Dspsbls and Accs · OneTouch Verio Reflect · Orbactiv · Otezla · Ozempic · PAXLOVID · PRADAXA · PREMARIN · PREVNAR 20 · QBREXZA · QULIPTA · QVAR · QVAR RediHaler · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SIVEXTRO · SOLIQUA · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYNJARDY · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULANCE · TRULICITY · TZIELD · ThinPrep · Tresiba · UBRELVY · VRAYLAR · Vascepa · Victoza · WATCHMAN Access System · Wellcentive Undiv · XARELTO · XIFAXAN · Xofluza · ZENPEP · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for internal medicine in IL.
Geographic Context
Internal medicine physicians within 10 mi
4,844
Per 100K population
93.4
County median income
$81,797
Nearest hospital
ST ALEXIUS MEDICAL CENTER
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bala is a clinical cardiology specialist, with above-average Medicare volume (top 14% in IL), with low-engagement industry engagement in the top 4% of IL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bala experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Bala performed 434 chronic care management, first 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bala receive payments from pharmaceutical companies?
Yes. Dr. Bala received a total of $18,522 from 57 companies across 849 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bala's costs compare to other internal medicine physicians in Schaumburg?
Dr. Bala's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bala) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Schaumburg
Browse internal medicine physicians in Schaumburg ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in IL
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in IL
Which IL internal medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology